Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia

International Journal of Infectious Diseases

Volumn 14, Issue 11, 2010, Pages

  Hamidinejat, Hossein ^a   Ghorbanpoor, Massoud ^a   Hosseini, Hamzeh ^a   Alavi, Seyed Mohammad ^a   Nabavi, Leili ^a   Jalali, Mohammad Hossein Razi ^a   Borojeni, Mehdi Pourmehdi ^a   Jafari, Hedieh ^a   Mohammadaligol, Sara ^a  

^a SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

Depressive disorder; Schizophrenia; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; IMMUNE STATUS; MAJOR CLINICAL STUDY; SCHIZOPHRENIA; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INPATIENTS; MIDDLE AGED; SCHIZOPHRENIA; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

EID: 78149465124     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.05.018     Document Type: Article

References (28)

1. Yolken R.H., Dickerson F.B., Fuller Torrey E. Toxoplasma and schizophrenia. Parasite Immunol 2009, 31:706-715.
2. Amminger G.P., McGorry P.D., Berger G.E., Wade D., Yung A.R., Phillips L.J., et al. Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol Psychiatry 2007, 61:1215-1217.
3. Flegr J., Preiss M., Klose J., Havlcek J., Vitkov M., Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii: dopamine, a missing link between schizophrenia and toxoplasmosis?. Biol Psychol 2003, 63:253-268.
4. Carter C.J. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophr Bull 2009, 35:1163-1182.
5. Cetinkaya Z., Yazar S., Gecici O., Namli M.N. Anti-Toxoplasma gondii antibodies in patients with schizophrenia-preliminary findings in a Turkish sample. Schizophr Bull 2007, 33:789-791.
6. Klevar S. Tissue cyst forming coccidian: Toxoplasma gondii and Neospora caninum as a cause of disease in farm animals. Acta Vet Scand 2007, 49(Suppl 1):S1.
7. Rorman E., Zamir C.S., Rilkis I., Ben-David H. Congenital toxoplasmosis-prenatal aspects of Toxoplasma gondii infection. Reprod Toxicol 2006, 21:458-472.
8. Dubey J.P. The history of Toxoplasma gondii-the first 100 years. J Eukaryot Microbiol 2008, 55:467-475.
9. Dubey J.P., Beattie C.P. Toxoplasmosis of animals and man 1988, CRC Press, Boca Raton. 1st ed.
10. Hunter C.A., Reichmann G. Immunology of Toxoplasma infection. Toxoplasma: the disease and its prevention 2001, 43-57. Cambridge University Press, Cambridge, UK. J. Johnson, T. Wreghitt (Eds.).
11. First M., Spitzer R., Gibbon M., Williams J. Structured clinical interview for DSM-IV axis 1 disorders (SCID-1), clinician version 1977, American Psychiatric Press, Washington, DC.
12. Swaen G., van Amelsvoort L. A weight of evidence approach to causal inference. J Clin Epidemiol 2009, 62:270-277.
13. Leweke F.M., Gerth C.W., Koethe D., Klosterkotter J., Ruslanova I., Krivogorsky B., et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004, 25:4-8.
14. Tamer G.S., Dundar D. The schizophrenia and Toxoplasma gondii connection: infectious, immune or both?. Adv Ther 2008, 25:703-709.
15. Fayer R. Toxoplasmosis update and public health implications. Canadian Vet J 1981, 22:344-352.
16. Tenter A.M., Heckeroth A.R., Weiss L.M. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000, 30:1217-1258.
17. Witting P.A. Learning capacity and memory of normal and Toxoplasma-infected laboratory rats and mice. Z Parasitenkd 1979, 61:29-51.
18. Webster J.P., Brunton C.F., Macdonald D.W. Effects of Toxoplasma gondii upon neophobia behavior in wild brown rats Rattus norvegicus. Parasitol 1994, 109:37-43.
19. Flegr J. Effects of Toxoplasma on human behavior. Schizophr Bull 2007, 33:757-760.
20. Havlicek J., Gasova Z., Smith A.P., Zvara K., Flegr J. Decrease of psychomotor performance in subjects with latent asymptomatic toxoplasmosis. Parasitology 2001, 122:515-520.
21. Stibbs H.H. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 1985, 79:153-157.
22. Webster J.P., Lamberton P.H., Donnelly C.A., Torrey E.F. Parasites as causative agents of human affective disorders? The impact of anti psychotic, mood-stabilizer and anti parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc Biol Sci 2006, 273:1023-1030.
23. Schwarcz R., Hunter C.A. Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?. Schizophr Bull 2007, 33:652-653.
24. Schwarcz R., Rassoulpour A., Wu H.Q., Medoff D., Tamminga C.A., Roberts R.C. Increased cortical kynurenate content in schizophrenia. Biol Psychiatry 2001, 50:521-530.
25. Schwarcz R., Pellicciari R. Manipulation of brain kynurenines: glial targets, neuronal effects and clinical opportunities. J Pharmacol Exp Ther 2002, 303:1-10.
26. Cotter D.R., Pariante C.M., Everall I.P. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 2001, 55:585-595.
27. Conejero-Goldberg C., Torrey E.F., Yolken R.H. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr Res 2003, 60:65-69.
28. Jones-Brando L., Fuller Torrey E., Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 2003, 62:237-244.